AML relapse after HSCT: trends and predictive factors
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2020-08-30
Просмотров: 750
Описание: Ali Bazarbachi, MD, PhD, of the American University of Beirut Medical Center, Beirut, Lebanon, outlines the trends and predictive factors for outcomes of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplant (HSCT) in young vs old patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: